연구동향 분석

Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma

Kim Hyun-Young Yoo In Young Lim Dae Jin Kim Hee-Jin Kim Sun-Hee Yoon Sang Eun Kim Seok Jin Cho Duck Kim Kihyun 2022년

논문상세정보
인용/피인용
' Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Progression-free survival
  • Minimal residual disease
  • Multiple myeloma
  • Next-generation flow cytometry
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
68 0

0.0%

' Clinical Utility of Next-Generation Flow-Based Minimal Residual Disease Assessment in Patients with Multiple Myeloma' 의 참고문헌

  • The clinical significance of stringent complete response in multiple myeloma is surpassed by minimal residual disease measurements
    Cedena MT [2020]
  • Pursuing a curative approach in multiple myeloma : a review of new therapeutic strategies
  • Next generation flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
  • Minimal residual disease negativity using deep sequencing is a major prognostic factor in multiple myeloma
    Perrot A [2018]
  • Minimal residual disease negativity does not overcome poor prognosis in high-risk multiple myeloma : A single-center retrospective study
  • Minimal residual disease in multiple myeloma : bringing the bench to the bedside
  • Minimal residual disease assessment within the bone marrow of multiple myeloma: a review of caveats, clinical significance and future perspectives
    Romano A [2019]
  • Meeting report : advances in minimal residual disease testing in multiple myeloma 2018
    Landgren O [2019]
  • International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
    Kumar , S. [2016]
  • Depth of response in multiple myeloma : a pooled analysis of three PETHEMA/GEM clinical trials
    Lahuerta JJ [2017]
  • Critical analysis of the stringent complete response in multiple myeloma : contribution of sFLC and bone marrow clonality
  • Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting
    Arroz M [2016]
  • Clinical applications and future directions of minimal residual disease testing in multiple myeloma
    Oliva S [2020]
  • Clinical Utility of a Diagnostic Approach to Detect Genetic Abnormalities in Multiple Myeloma: A Single Institution Experience
    정현애 [2018]
  • Challenges and opportunities in the assessment of measurable residual disease in multiple myeloma
    Bal S [2019]
  • Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma : A Meta-analysis
  • Application of Next Generation Sequencing in Laboratory Medicine